Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped. Yahoo Finance host Josh Lipton breaks down the day's top ...
Vertex Pharmaceuticals Incorporated (VRTX) stock price is 461.68 and Vertex Pharmaceuticals Incorporated (VRTX) 10-day simple moving average is 438.34. Vertex Pharmaceuticals Incorporated (VRTX ...
After hours: January 31 at 7:56:30 PM EST ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Guj Terce Labs Standalone June 2024 Net Sales at Rs 11.89 crore, up 10.93% Y-o-Y Aug 13 2024 01:37 PM Guj Terce Labs Standalone March 2024 Net Sales at Rs 12.21 crore, down 5.29% Y-o-Y Jun 07 2024 ...
Ambalal Sarabha Consolidated June 2024 Net Sales at Rs 40.70 crore, up 12.73% Y-o-Y Aug 21 2024 01:17 PM Ambalal Sarabha Standalone June 2024 Net Sales at Rs 1.14 crore, down 32.95% Y-o-Y Aug 13 ...
Financial giants have made a conspicuous bearish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...
NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...